92 related articles for article (PubMed ID: 32133644)
1. Glucocorticoids delivered by inorganic-organic hybrid nanoparticles mitigate acute graft-versus-host disease and sustain graft-versus-leukemia activity.
Kaiser TK; Li H; Roßmann L; Reichardt SD; Bohnenberger H; Feldmann C; Reichardt HM
Eur J Immunol; 2020 Aug; 50(8):1220-1233. PubMed ID: 32133644
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Fluorescent Hybrid Nanoparticles for Traceable Delivery of Glucocorticoids to Inflammatory Sites.
Napp J; Markus MA; Heck JG; Dullin C; Möbius W; Gorpas D; Feldmann C; Alves F
Theranostics; 2018; 8(22):6367-6383. PubMed ID: 30613305
[TBL] [Abstract][Full Text] [Related]
3. Targeted delivery of glucocorticoids to macrophages in a mouse model of multiple sclerosis using inorganic-organic hybrid nanoparticles.
Montes-Cobos E; Ring S; Fischer HJ; Heck J; Strauß J; Schwaninger M; Reichardt SD; Feldmann C; Lühder F; Reichardt HM
J Control Release; 2017 Jan; 245():157-169. PubMed ID: 27919626
[TBL] [Abstract][Full Text] [Related]
4. HIF-1α inhibitor echinomycin reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect.
Yao Y; Wang L; Zhou J; Zhang X
J Transl Med; 2017 Feb; 15(1):28. PubMed ID: 28183349
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoid resistance of allogeneic T cells alters the gene expression profile in the inflamed small intestine of mice suffering from acute graft-versus-host disease.
Li H; Kaiser TK; Borschiwer M; Bohnenberger H; Reichardt SD; Lühder F; Walter L; Dressel R; Meijsing SH; Reichardt HM
J Steroid Biochem Mol Biol; 2019 Dec; 195():105485. PubMed ID: 31561002
[TBL] [Abstract][Full Text] [Related]
6. Highly selective organ distribution and cellular uptake of inorganic-organic hybrid nanoparticles customized for the targeted delivery of glucocorticoids.
Kaiser TK; Khorenko M; Moussavi A; Engelke M; Boretius S; Feldmann C; Reichardt HM
J Control Release; 2020 Mar; 319():360-370. PubMed ID: 31923534
[TBL] [Abstract][Full Text] [Related]
7. The Ex Vivo Treatment of Donor T Cells with Cosalane, an HIV Therapeutic and Small-Molecule Antagonist of CC-Chemokine Receptor 7, Separates Acute Graft-versus-Host Disease from Graft-versus-Leukemia Responses in Murine Hematopoietic Stem Cell Transplantation Models.
Fowler KA; Li K; Whitehurst CB; Bruce DW; Moorman NJ; Aubé J; Coghill JM
Biol Blood Marrow Transplant; 2019 Jun; 25(6):1062-1074. PubMed ID: 30668984
[TBL] [Abstract][Full Text] [Related]
8. IL-12/IL-18-preactivated donor NK cells enhance GVL effects and mitigate GvHD after allogeneic hematopoietic stem cell transplantation.
Song Y; Hu B; Liu Y; Jin Z; Zhang Y; Lin D; Zhu Y; Lei L; Gong H; Mei Y; Teo HY; Wu D; Liu H
Eur J Immunol; 2018 Apr; 48(4):670-682. PubMed ID: 29282719
[TBL] [Abstract][Full Text] [Related]
9. IL-22 deficiency in donor T cells attenuates murine acute graft-versus-host disease mortality while sparing the graft-versus-leukemia effect.
Couturier M; Lamarthée B; Arbez J; Renauld JC; Bossard C; Malard F; Bonnefoy F; Mohty M; Perruche S; Tiberghien P; Saas P; Gaugler B
Leukemia; 2013 Jul; 27(7):1527-37. PubMed ID: 23399894
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoids attenuate acute graft-versus-host disease by suppressing the cytotoxic capacity of CD8(+) T cells.
Theiss-Suennemann J; Jörß K; Messmann JJ; Reichardt SD; Montes-Cobos E; Lühder F; Tuckermann JP; AWolff H; Dressel R; Gröne HJ; Strauß G; Reichardt HM
J Pathol; 2015 Mar; 235(4):646-55. PubMed ID: 25358639
[TBL] [Abstract][Full Text] [Related]
11. Repifermin (keratinocyte growth factor-2) reduces the severity of graft-versus-host disease while preserving a graft-versus-leukemia effect.
Clouthier SG; Cooke KR; Teshima T; Lowler KP; Liu C; Connolly K; Ferrara JL
Biol Blood Marrow Transplant; 2003 Sep; 9(9):592-603. PubMed ID: 14506661
[TBL] [Abstract][Full Text] [Related]
12. Preimplantation factor reduces graft-versus-host disease by regulating immune response and lowering oxidative stress (murine model).
Azar Y; Shainer R; Almogi-Hazan O; Bringer R; Compton SR; Paidas MJ; Barnea ER; Or R
Biol Blood Marrow Transplant; 2013 Apr; 19(4):519-28. PubMed ID: 23266739
[TBL] [Abstract][Full Text] [Related]
13. Tryptophan metabolite analog, N-(3,4-dimethoxycinnamonyl) anthranilic acid, ameliorates acute graft-versus-host disease through regulating T cell proliferation and polarization.
Xu J; Wei J; Huang M; Zhu X; Guan J; Yin J; Xiao Y; Zhang Y
Int Immunopharmacol; 2013 Nov; 17(3):601-7. PubMed ID: 23993943
[TBL] [Abstract][Full Text] [Related]
14. Ex vivo fludarabine exposure inhibits graft-versus-host activity of allogeneic T cells while preserving graft-versus-leukemia effects.
Giver CR; Montes RO; Mittelstaedt S; Li JM; Jaye DL; Lonial S; Boyer MW; Waller EK
Biol Blood Marrow Transplant; 2003 Oct; 9(10):616-32. PubMed ID: 14569558
[TBL] [Abstract][Full Text] [Related]
15. [Effects of immature dendritic cells genetically modified to express sTNFR I on graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) in allogeneic bone marrow transplantation mice].
Wang SH; Li DP; Zhang YJ; Zhang P; Zeng LY; Pan XY; Xu KL; Huang YH
Zhonghua Xue Ye Xue Za Zhi; 2012 Feb; 33(2):88-93. PubMed ID: 22730654
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid Nanoparticles Show Full Therapeutic Efficacy in a Mouse Model of Acute Lung Injury and Concomitantly Reduce Adverse Effects.
Albers GJ; Amouret A; Ciupka K; Montes-Cobos E; Feldmann C; Reichardt HM
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069173
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid and glycolysis inhibitors cooperatively abrogate acute graft-versus-host disease.
Wen Q; Xu ZL; Wang Y; Lv M; Song Y; Lyv ZS; Xing T; Xu LP; Zhang XH; Huang XJ; Kong Y
Sci China Life Sci; 2023 Mar; 66(3):528-544. PubMed ID: 36166182
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometric analysis of the graft-versus-Leukemia-effect after hematopoietic stem cell transplantation in mice.
Schmidt F; Hilger N; Oelkrug C; Svanidze E; Ruschpler P; Eichler W; Boldt A; Emmrich F; Fricke S
Cytometry A; 2015 Apr; 87(4):334-45. PubMed ID: 25717029
[TBL] [Abstract][Full Text] [Related]
19. During acute graft versus host disease CD28 deletion in donor CD8
Uri A; Lühder F; Kerkau T; Beyersdorf N
Eur J Immunol; 2018 Dec; 48(12):2055-2067. PubMed ID: 30320878
[TBL] [Abstract][Full Text] [Related]
20. [The effect of HGF on graft-versus-host disease and graft-versus-leukemia after allogeneic bone marrow transplantation in acute lymphoblastic leukemia mice].
Xia YJ; Gao QP; Wan CC; Cheng FJ; Liu ZX; Guo RC
Zhonghua Xue Ye Xue Za Zhi; 2005 Jul; 26(7):404-7. PubMed ID: 16251021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
